Abstract
Previous studies have shown that human dihydrofolate reductase (DHFR) acts as an RNA-binding protein, in which it binds to its own mRNA and, in so doing, results in translational repression. In this study, we used RNA gel mobility shift and nitrocellulose filter-binding assays to further investigate the specificity of the interaction between human DHFR protein and human DHFR mRNA. Site-directed mutagenesis was used to identify the critical amino acid residues on DHFR protein required for RNA recognition. Human His-Tag DHFR protein specifically binds to human DHFR mRNA, while unrelated proteins including thymidylate synthase, p53 and glutathione-S-transferase were unable to form a ribonucleoprotein complex with DHFR mRNA. The Cys6 residue is essential for RNA recognition, as mutation at this amino acid with either an alanine (C6A) or serine (C6S) residue almost completely abrogated RNA-binding activity. Neither one of the cysteine mutant proteins was able to repress the in vitro translation of human DHFR mRNA. Mutations at amino acids Ile7, Arg28 and Phe34, significantly reduced RNA-binding activity. An RNA footprinting analysis identified three different RNA sequences, bound to DHFR protein, ranging in size from 16 to 45 nt, while a UV cross-linking analysis isolated an approximately 16 nt RNA sequence bound to DHFR. These studies begin to identify the critical amino acid residues on human DHFR that mediate RNA binding either through forming direct contact points with RNA or through maintaining the protein in an optimal structure that allows for the critical RNA-binding domain to be accessible.
MeSH Terms
Amino Acids/analysis
Binding Sites
Humans
Macromolecular Substances
Molecular Weight
Protein Biosynthesis
RNA, Messenger/metabolism
RNA-Binding Proteins/chemistry,genetics,metabolism
Ribonucleoproteins/metabolism
Tetrahydrofolate Dehydrogenase/chemistry,genetics,metabolism
Ultraviolet Rays
Chemicals
Amino Acids
Macromolecular Substances
RNA, Messenger
RNA-Binding Proteins
Ribonucleoproteins
Tetrahydrofolate Dehydrogenase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tai Ningwen
Department of Medicine and Pharmacology, Yale Cancer Center, Yale University School of Medicine and VA Connecticut Healthcare System, New Haven, CT 06520, USA.
Ding Yuyan
Schmitz John C
Chu Edward
References (30)
30 references, click to expand
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063
-
The effect of polyoma virus, serum factors, and dibutyryl cyclic AMP on dihydrofolate reductase synthesis, and the entry of quiescent cells into S phase.
J Cell Physiol. 1981 Jul;108(1):1-8
PMID: 6267077
-
Control of cellular gene expression during adenovirus infection: induction and shut-off of dihydrofolate reductase gene expression by adenovirus type 2.
Mol Cell Biol. 1983 May;3(5):819-28
PMID: 6865943
-
The intracellular content of dihydrofolate reductase: possibilities for control and implications for chemotherapy.
Adv Enzyme Regul. 1984;22:15-26
PMID: 6475640
-
Determinants of trimetrexate lethality in human colon cancer cells.
Br J Cancer. 1994 Dec;70(6):1075-84
PMID: 7981057
-
Regulating the fate of mRNA: the control of cellular iron metabolism.
Cell. 1993 Jan 15;72(1):19-28
PMID: 8380757
-
Cell cycle regulation of dihydrofolate reductase mRNA metabolism in mouse fibroblasts.
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5140-4
PMID: 6933549
-
Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis.
Biochemistry. 1994 Aug 23;33(33):9945-52
PMID: 8061003
-
Regulation of ferritin and transferrin receptor mRNAs.
J Biol Chem. 1990 Mar 25;265(9):4771-4
PMID: 2156853
-
Polyoma virus and cyclic AMP-mediated control of dihydrofolate reductase mRNA abundance in methotrexate-resistant mouse fibroblasts.
J Biol Chem. 1979 Jan 25;254(2):309-18
PMID: 216671
-
Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate.
Proc Natl Acad Sci U S A. 1967 Oct;58(4):1632-7
PMID: 4230391
-
A covalent adduct between the uracil ring and the active site of an aminoacyl tRNA synthetase.
Nature. 1982 Jul 8;298(5870):136-40
PMID: 7045689
-
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8977-81
PMID: 1924359
-
Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
J Biol Chem. 1988 Jul 15;263(20):9840-7
PMID: 2838483
-
Purification and characterization of dihydrofolate reductase from methotrexate-resistant human lymphoblastoid cells.
Biochemistry. 1983 Feb 1;22(3):633-9
PMID: 6838817
-
Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutants.
Hum Gene Ther. 1997 Nov 20;8(17):2069-77
PMID: 9414255
-
Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
Mol Pharmacol. 1982 Mar;21(2):478-82
PMID: 7099148
-
Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding site.
Biochemistry. 1983 May 24;22(11):2601-10
PMID: 6347247
-
Identification of an RNA binding site for human thymidylate synthase.
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):517-21
PMID: 8421684
-
Conversion of arginine to lysine at position 70 of human dihydrofolate reductase: generation of a methotrexate-insensitive mutant enzyme.
Biochemistry. 1991 Aug 20;30(33):8124-30
PMID: 1907850
-
Dismutation of dihydrofolate by dihydrofolate reductase.
Biochemistry. 1984 May 22;23(11):2377-83
PMID: 6433972
-
Nucleoside and nucleotide inactivation of R17 coat protein: evidence for a transient covalent RNA-protein bond.
Biochemistry. 1985 Jul 16;24(15):4239-44
PMID: 4052393
-
Induction of dihydrofolate reductase activity by SV40 and polyoma virus.
Cancer Res. 1966 Aug;26(8):1653-60
PMID: 4288549
-
Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
Mol Pharmacol. 1986 Jul;30(1):69-76
PMID: 3724746
-
Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants.
Cancer Res. 1998 May 15;58(10):2091-4
PMID: 9605749
-
Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro.
Biochemistry. 1993 May 11;32(18):4756-60
PMID: 8490020
-
Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2171-5
PMID: 3127826
-
Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers.
J Biol Chem. 1995 Mar 10;270(10):5057-64
PMID: 7890613
-
Characterization of a specific interaction between Escherichia coli thymidylate synthase and Escherichia coli thymidylate synthase mRNA.
Nucleic Acids Res. 1995 Mar 11;23(5):869-75
PMID: 7708505
-
Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.
Biochemistry. 1997 Oct 7;36(40):12317-22
PMID: 9315871